Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 24 matching records.
24 results — page 1 of 1
- Level DAnimal StudyEurope PMC
Ex Vivo Regional Gene Therapy Compared to Recombinant BMP-2 for the Treatment of Critical-Size Bone Defects: An In Vivo Single-Cell RNA-Sequencing Study
Animal Study on Cartilage Damage, Chronic Inflammation, published in Bioengineering (Basel) (2025) — summary generated from the PubMed abstract.
- 2025
Bioengineering (Basel)2 citations - Level DNarrative ReviewEurope PMC
Treatment of large bone defects in load-bearing bone: traditional and novel bone grafts
Narrative Review, published in J Zhejiang Univ Sci B (2025) — summary generated from the PubMed abstract.
- 2025
J Zhejiang Univ Sci B5 citations - Level DNarrative ReviewEurope PMC
Research progress of 3D-printed PLGA scaffolds for the treatment of bone defects
Narrative Review, published in Biomed Eng Online (2025) — summary generated from the PubMed abstract.
- 2025
Biomed Eng Online2 citations - Level DLaboratory StudyEurope PMC
Update on the use of 45S5 bioactive glass in the treatment of bone defects in regenerative medicine
Laboratory Study, published in World J Orthop (2024) — summary generated from the PubMed abstract.
- 2024
World J Orthop7 citations - Level DAnimal StudyEurope PMC
Localized delivery of metformin via 3D printed GelMA-Nanoclay hydrogel scaffold for enhanced treatment of diabetic bone defects
Animal Study on Immune Modulation, published in J Orthop Translat (2024) — summary generated from the PubMed abstract.
- 2024
J Orthop Translat10 citations - Level DNarrative ReviewEurope PMC
Treatment of Bone Defects and Nonunion via Novel Delivery Mechanisms, Growth Factors, and Stem Cells: A Review
Narrative Review, published in ACS Biomater Sci Eng (2024) — summary generated from the PubMed abstract.
- 2024
ACS Biomater Sci Eng9 citations - Level DNarrative ReviewEurope PMC
Scaffold Guided Bone Regeneration for the Treatment of Large Segmental Defects in Long Bones
Narrative Review on Face & Skin, published in Biomedicines (2023) — summary generated from the PubMed abstract.
- 2023
Biomedicines31 citations - Level DNarrative ReviewEurope PMC
Advances in the Development of Nano-Engineered Mechanically Robust Hydrogels for Minimally Invasive Treatment of Bone Defects
Narrative Review, published in Gels (2023) — summary generated from the PubMed abstract.
- 2023
Gels5 citations - Level DAnimal StudyPubMed
Point-of-care treatment of geometrically complex midfacial critical-sized bone defects with 3D-Printed scaffolds and autologous stromal vascular fraction.
Animal Study on Face & Skin, published in Biomaterials (2022) — summary generated from the PubMed abstract.
- 2022
Biomaterials17 citations - Level DNarrative ReviewPubMed
Bone Healing Materials in the Treatment of Recalcitrant Nonunions and Bone Defects.
Narrative Review, published in Int J Mol Sci (2022) — summary generated from the PubMed abstract.
- 2022
Int J Mol Sci - Level DNarrative ReviewEurope PMC
Bone Tissue Engineering in the Treatment of Bone Defects
Narrative Review, published in Pharmaceuticals (Basel) (2022) — summary generated from the PubMed abstract.
- 2022
Pharmaceuticals (Basel)199 citations - Level CProspective StudyPubMed
A Three-Dimensional Printed Polycaprolactone-Biphasic-Calcium-Phosphate Scaffold Combined with Adipose-Derived Stem Cells Cultured in Xenogeneic Serum-Free Media for the Treatment of Bone Defects.
Prospective Study, published in J Funct Biomater (2022) — summary generated from the PubMed abstract.
- 2022
J Funct Biomater4 citations - Level DLaboratory StudyEurope PMC
(Bio)manufactured Solutions for Treatment of Bone Defects with Emphasis on US-FDA Regulatory Science Perspective
Laboratory Study, published in Adv Nanobiomed Res (2022) — summary generated from the PubMed abstract.
- 2022
Adv Nanobiomed Res26 citations - Level DAnimal StudyEurope PMC
Three-dimensional printed polylactic acid and hydroxyapatite composite scaffold with urine-derived stem cells as a treatment for bone defects
Animal Study, published in J Mater Sci Mater Med (2022) — summary generated from the PubMed abstract.
- 2022
J Mater Sci Mater Med10 citations - Level DAnimal StudyPubMed
Autologous cell-coated particles for the treatment of segmental bone defects-a new cell therapy approach.
Animal Study, published in J Orthop Surg Res (2019) — summary generated from the PubMed abstract.
- 2019
J Orthop Surg Res4 citations - Level DNarrative ReviewEurope PMC
Exosomes in the Repair of Bone Defects: Next-Generation Therapeutic Tools for the Treatment of Nonunion
Narrative Review on Hip, published in Biomed Res Int (2019) — summary generated from the PubMed abstract.
- 2019
Biomed Res Int25 citations - Level BClinical TrialEurope PMC
Autologous cell-based therapy for treatment of large bone defects: from bench to bedside
Clinical Trial, published in Eur J Trauma Emerg Surg (2018) — summary generated from the PubMed abstract.
- 2018
Eur J Trauma Emerg Surg46 citations - Level DAnimal StudyPubMed
Low power laser irradiation and human adipose-derived stem cell treatments promote bone regeneration in critical-sized calvarial defects in rats.
Animal Study, published in PLoS One (2018) — summary generated from the PubMed abstract.
- 2018
PLoS One30 citations - Level DAnimal StudyEurope PMC
Evaluation of bone regeneration potential of dental follicle stem cells for treatment of craniofacial defects
Animal Study on Face & Skin, Hair & Scalp, published in Cytotherapy (2015) — summary generated from the PubMed abstract.
- 2015
Cytotherapy47 citations - Level DAnimal StudyPubMed
Treatment of Peri-Implant Defects in the Rabbit's Tibia with Adipose or Bone Marrow-Derived Mesenchymal Stems Cells.
Animal Study, published in Clin Implant Dent Relat Res (2015) — summary generated from the PubMed abstract.
- 2015
Clin Implant Dent Relat Res - Level DLaboratory StudyPubMed
A new choice for the treatment of segmental tibial bone defects: intramedullary nail internal fixation combined adipose-derived stem cells technique.
Laboratory Study, published in Med Hypotheses (2013) — summary generated from the PubMed abstract.
- 2013
Med Hypotheses2 citations - Level BRandomized Controlled TrialPubMed
Nonprocessed adipose tissue graft in the treatment of dehiscence bone defects in rabbit tibiae: a pilot study.
Randomized Controlled Trial, published in Implant Dent (2012) — summary generated from the PubMed abstract.
- 2012
Implant Dent - Level DLaboratory StudyPubMed
Adipose derived stem cells for treatment of mandibular bone defects: An autologous study in dogs.
Laboratory Study, published in Dent Res J (Isfahan) (2011) — summary generated from the PubMed abstract.
- 2011
Dent Res J (Isfahan)12 citations - Level DNarrative ReviewEurope PMC
Segmental bone defects: from cellular and molecular pathways to the development of novel biological treatments
Narrative Review, published in J Cell Mol Med (2010) — summary generated from the PubMed abstract.
- 2010
J Cell Mol Med59 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406